Insights

IP Roundtable (San Francisco) - Gene Patenting in the US After Myriad

Name: IP Roundtable (San Francisco) - Gene Patenting in the US After Myriad
Start: 2012-01-18T12:00:00+0000
Location: N/A

When: 1/18/2012 12:00pm – 1:30pm

Speakers: Eugene Y. Mar

Eugen Mar and Julie Wahlstrand, Moderators, "Gene Patenting in the US After Myriad"

Farella Braun + Martel LLP
San Francisco, CA

Firm Highlights

News

Farella Braun + Martel Ranked Among Top 50 for Patent Litigation by Patexia

Farella Braun + Martel was ranked among the Top 50 law firms for patent litigation in Patexia's 2026 Patent Litigation Intelligence Report . Intellectual Property Partner Eugene Mar was ranked among the Top 100 patent...

News

What I Heard at ACTL’s Trial Advocacy Program in SF: Better Crosses, Stronger Voices, Real Concern

Jeff Fisher was quoted in the June 2, 2026, Law.com Litigation Daily feature, "What I Heard at ACTL’s Trial Advocacy Program in SF: Better Crosses, Stronger Voices, Real Concern." The column was about the American...

Publication

Why Distinguishing Trade Secrets From Public Knowledge Matters

Publication

IP Roundtable (San Francisco) - Gene Patenting in the US After Myriad

Firm Highlights

Farella’s Eugene Mar Named Among Daily Journal’s Top IP Lawyers

Risk of Developing Your Own Competing Software to White-Labeled Software

Recovering Avoided Costs as Damages (Part 2)?

Can Avoided Costs Be Another Form of Damages?

To Apportion or Not Apportion Trade Secret Damages

The Tension Between Trade Secrets and Patents

Farella Braun + Martel Ranked Among Top 50 for Patent Litigation by Patexia

What I Heard at ACTL’s Trial Advocacy Program in SF: Better Crosses, Stronger Voices, Real Concern

Why Distinguishing Trade Secrets From Public Knowledge Matters

When You Have a Basis To File a Trade Secret Lawsuit